Gómez-Gaviro M V, Domínguez-Jiménez C, Carretero J M, Sabando P, González-Alvaro I, Sánchez-Madrid F, Díaz-González F
Servicio de Reumatología e Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Servicio de Reumatología, Hospital Tenerife, Spain.
Blood. 2000 Nov 15;96(10):3592-600.
L-selectin is an adhesion molecule that plays an essential role in the early events of the inflammatory response. Our group has recently described that several nonsteroidal anti-inflammatory drugs (NSAIDs) are able to induce both in vivo and in vitro the shedding of L-selectin in neutrophils through an unknown mechanism. In this work, we have studied potential mechanisms involved in the shedding of L-selectin induced by NSAIDs. This effect of NSAIDs did not involve any detectable intracellular calcium flux. Pretreatment of neutrophils either with Ro 31-8220 and H7, 2 specific inhibitors of protein kinase C (PKC), or with inhibitors of protein tyrosine kinases such as tyrphostin A25 or herbimycin A did not prevent the NSAID-mediated L-selectin shedding. However, the KD-IX-73-4, an inhibitor of L-selectin proteolysis was able to block the effect of NSAIDs on L-selectin expression. Remarkably, NSAIDs caused a variable reduction in the neutrophil intracellular ATP concentration that highly correlated with the differential ability of NSAIDs to trigger L-selectin shedding (r = 0.8, P <.01). In agreement with this finding, azide plus 2-deoxy-D-glucose, 2 metabolic blockers, also induced a rapid L-selectin shedding (65% +/- 8%) without affecting the neutrophil viability, activation, or expression level of other surface molecules with soluble isoforms such as CD16 and CD59. These data indicate that the maintenance of L-selectin on the neutrophil surface requires energy consumption, which suggests that L-selectin is shed in neutrophils by default. Interestingly, NSAIDs seem to cause the shedding of L-selectin, at least in part, through the reduction of the intracellular ATP concentration.
L-选择素是一种黏附分子,在炎症反应的早期事件中起关键作用。我们的研究小组最近报道,几种非甾体抗炎药(NSAIDs)能够通过未知机制在体内和体外诱导中性粒细胞中L-选择素的脱落。在这项研究中,我们探讨了NSAIDs诱导L-选择素脱落的潜在机制。NSAIDs的这种作用不涉及任何可检测到的细胞内钙流。用蛋白激酶C(PKC)的两种特异性抑制剂Ro 31-8220和H7,或蛋白酪氨酸激酶抑制剂如 tyrphostin A25或赫曲霉素A预处理中性粒细胞,均不能阻止NSAIDs介导的L-选择素脱落。然而,L-选择素蛋白水解抑制剂KD-IX-73-4能够阻断NSAIDs对L-选择素表达的影响。值得注意的是,NSAIDs导致中性粒细胞内ATP浓度不同程度降低,这与NSAIDs引发L-选择素脱落的不同能力高度相关(r = 0.8,P <.01)。与此发现一致,叠氮化物加2-脱氧-D-葡萄糖这两种代谢阻滞剂也能快速诱导L-选择素脱落(65%±8%),且不影响中性粒细胞活力、活化或其他具有可溶性异构体的表面分子如CD16和CD59的表达水平。这些数据表明,L-选择素在中性粒细胞表面的维持需要能量消耗,这表明L-选择素在中性粒细胞中是默认脱落的。有趣的是,NSAIDs似乎至少部分通过降低细胞内ATP浓度导致L-选择素脱落。